Long-Circulating and Fusogenic Liposomes Loaded with Paclitaxel and Doxorubicin: Effect of Excipient, Freezing, and Freeze-Drying on Quality Attributes
Liposomes can increase plasma half-life, enhance targeting, and diminish the side-effects of loaded drugs. On the downside, physical and chemical instabilities of dispersions often result in a reduced lifespan, which limits their availability on the market. Solid formulations obtained by freeze-dryi...
Main Authors: | Marjorie Roque, Danilo Geraldes, Caroline da Silva, Mônica Oliveira, Laura Nascimento |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/86 |
Similar Items
-
Remote loading paclitaxel–doxorubicin prodrug into liposomes for cancer combination therapy
by: Jiang Yu, et al.
Published: (2020-09-01) -
Case Report: Postoperative Recurrence of Adrenal Epithelioid Angiosarcoma Achieved Complete Response by Combination Chemotherapy With Liposomal Doxorubicin and Paclitaxel
by: Hangping Wei, et al.
Published: (2021-12-01) -
Study of the Freezing Behavior of Liposomes
by: Masayuki KOBAYASHI, et al.
Published: (2011-03-01) -
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes
by: Alberto Gabizon, et al.
Published: (2023-11-01) -
A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer
by: Yinjuan Li, et al.
Published: (2022-12-01)